- Release Date: 08/01/16 09:17
- Summary: FDA Allows PTX IND for Leukemia Phase Ib & II Trials
- Price Sensitive: Yes
- Download Document 332.21KB
- Forums
- ASX - By Stock
- PTX
- Ann: FDA Allows PTX IND for Leukemia Phase Ib & II Trials
Ann: FDA Allows PTX IND for Leukemia Phase Ib & II Trials
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.3¢ |
Change
-0.001(2.27%) |
Mkt cap ! $34.62M |
Open | High | Low | Value | Volume |
4.3¢ | 4.3¢ | 4.3¢ | $4.3K | 100K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 182525 | 4.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 8200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 162069 | 0.043 |
4 | 282657 | 0.042 |
6 | 439000 | 0.041 |
9 | 1349510 | 0.040 |
2 | 210000 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 8200 | 1 |
0.045 | 26000 | 1 |
0.048 | 2664 | 1 |
0.049 | 70000 | 1 |
0.051 | 277227 | 2 |
Last trade - 10.22am 21/10/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online